JP Morgan Chase
TYRA icon

JP Morgan Chase’s Tyra Biosciences TYRA Stock Holding History

JP Morgan Chase’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74M Buy
178,263
+111,474
+167% +$3.69M ﹤0.01% 3332
2026
Q1 		$2.31M Sell
66,789
-4,386
-6% -$142K ﹤0.01% 3993
2025
Q4 		$1.87M Sell
71,175
-3,054
-4% -$56.1K ﹤0.01% 4121
2025
Q3 		$1.04M Sell
74,229
-28,688
-28% -$327K ﹤0.01% 4558
2025
Q2 		$985K Buy
102,917
+17,427
+20% +$166K ﹤0.01% 4391
2025
Q1 		$795K Sell
85,490
-5,625
-6% -$72.8K ﹤0.01% 4494
2024
Q4 		$1.27M Sell
91,115
-277,532
-75% -$5.04M ﹤0.01% 4458
2024
Q3 		$8.67M Buy
368,647
+3,896
+1% +$81.8K ﹤0.01% 2731
2024
Q2 		$5.83M Sell
364,751
-15,846
-4% -$273K ﹤0.01% 2919
2024
Q1 		$6.24M Sell
380,597
-21,109
-5% -$346K ﹤0.01% 2901
2023
Q4 		$5.56M Buy
401,706
+4,088
+1% +$52.9K ﹤0.01% 2984
2023
Q3 		$5.48M Sell
397,618
-25,803
-6% -$383K ﹤0.01% 2763
2023
Q2 		$7.21M Buy
423,421
+230,912
+120% +$3.35M ﹤0.01% 2575
2023
Q1 		$3.09M Sell
192,509
-6,698
-3% -$79.7K ﹤0.01% 3193
2022
Q4 		$1.51M Sell
199,207
-20,340
-9% -$144K ﹤0.01% 3772
2022
Q3 		$1.93M Sell
219,547
-4,945
-2% -$45.2K ﹤0.01% 3498
2022
Q2 		$1.6M Sell
224,492
-3,990
-2% -$31.8K ﹤0.01% 3719
2022
Q1 		$2.44M Buy
228,482
+73,903
+48% +$877K ﹤0.01% 3604
2021
Q4 		$2.17M Buy
+154,579
New +$3.07M ﹤0.01% 3797

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

JP Morgan Chase's TYRA Position: Q2 2026 in Review

JP Morgan Chase increased its Tyra Biosciences (TYRA) stake by 167% in Q2 2026, buying an estimated $3.69M and bringing the position to 178,263 shares worth $5.74M. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

JP Morgan Chase first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.67M in Q3 2024. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • JP Morgan Chase held 178,263 shares of Tyra Biosciences worth $5.74M as of Q2 2026.
  • JP Morgan Chase bought 111,474 Tyra Biosciences shares in Q2 2026, an estimated $3.69M.
  • Tyra Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3332 holding.
  • JP Morgan Chase first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Tyra Biosciences position peaked at $8.67M in Q3 2024.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.